[PDF][PDF] Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection
LK Tanwani, SPL Mokshagundam - 2003 - academia.edu
The introduction of highly active antiretroviral therapy has significantly reduced morbidity
and mortality in patients infected with the human immunodeficiency virus. Treatment with …
and mortality in patients infected with the human immunodeficiency virus. Treatment with …
Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.(Featured CME Topic …
LK Tanwani, SPL Mokshagundam - Southern Medical Journal, 2003 - go.gale.com
The introduction of highly active antiretroviral therapy has significantly reduced morbidity
and mortality in patients infected with the human immunodeficiency virus. Treatment with …
and mortality in patients infected with the human immunodeficiency virus. Treatment with …
Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.
LK Tanwani, SL Mokshagundam - 2003 - cabidigitallibrary.org
The introduction of highly active antiretroviral therapy has significantly reduced morbidity
and mortality in patients infected with the human immunodeficiency virus. Treatment with …
and mortality in patients infected with the human immunodeficiency virus. Treatment with …
Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection
LK Tanwani… - Southern medical …, 2003 - pubmed.ncbi.nlm.nih.gov
The introduction of highly active antiretroviral therapy has significantly reduced morbidity
and mortality in patients infected with the human immunodeficiency virus. Treatment with …
and mortality in patients infected with the human immunodeficiency virus. Treatment with …
Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.
LK Tanwani, SL Mokshagundam - Southern Medical Journal, 2003 - europepmc.org
The introduction of highly active antiretroviral therapy has significantly reduced morbidity
and mortality in patients infected with the human immunodeficiency virus. Treatment with …
and mortality in patients infected with the human immunodeficiency virus. Treatment with …
[引用][C] Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection
LK TANWANI… - Southern medical journal …, 2003 - pascal-francis.inist.fr
Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular
disease in human immunodeficiency virus infection CNRS Inist Pascal-Francis CNRS …
disease in human immunodeficiency virus infection CNRS Inist Pascal-Francis CNRS …